This is a table of type quadgram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
quadgram | frequency |
---|---|
middle east respiratory syndrome | 6092 |
east respiratory syndrome coronavirus | 4733 |
severe acute respiratory syndrome | 2409 |
of middle east respiratory | 1902 |
acute respiratory syndrome coronavirus | 1046 |
respiratory syndrome coronavirus infection | 729 |
of severe acute respiratory | 725 |
the middle east respiratory | 575 |
respiratory syndrome coronavirus in | 444 |
with middle east respiratory | 413 |
acute respiratory distress syndrome | 412 |
for the treatment of | 365 |
of a novel coronavirus | 363 |
for middle east respiratory | 307 |
a novel coronavirus from | 291 |
in the middle east | 278 |
the severe acute respiratory | 278 |
outbreak of middle east | 274 |
with severe acute respiratory | 270 |
the republic of korea | 257 |
of the middle east | 243 |
novel coronavirus from a | 229 |
pneumonia in saudi arabia | 228 |
isolation of a novel | 226 |
from a man with | 226 |
a man with pneumonia | 225 |
the world health organization | 224 |
with pneumonia in saudi | 224 |
disease control and prevention | 224 |
coronavirus from a man | 224 |
man with pneumonia in | 223 |
for disease control and | 215 |
patients with middle east | 213 |
in the republic of | 211 |
in the treatment of | 209 |
syndrome coronavirus infection in | 203 |
critically ill patients with | 195 |
kingdom of saudi arabia | 194 |
in the united states | 193 |
in the context of | 191 |
in the case of | 185 |
in patients with severe | 183 |
cases of middle east | 179 |
in the absence of | 166 |
arabia middle east respiratory | 165 |
saudi arabia middle east | 165 |
on the other hand | 164 |
outbreak in south korea | 160 |
and clinical characteristics of | 159 |
centers for disease control | 159 |
in the presence of | 159 |
a functional receptor for | 154 |
patients with severe acute | 151 |
as well as the | 150 |
in dromedary camels in | 149 |
infection prevention and control | 142 |
characteristics of cases of | 141 |
is a functional receptor | 141 |
clinical characteristics of cases | 138 |
functional receptor for the | 138 |
hospital outbreak of middle | 137 |
the lower respiratory tract | 137 |
the treatment of covid | 134 |
case of middle east | 133 |
for the development of | 130 |
respiratory syndrome coronavirus infections | 130 |
and middle east respiratory | 126 |
the spike protein of | 124 |
in the arabian peninsula | 120 |
with acute respiratory distress | 120 |
in the lungs of | 118 |
in vitro and in | 118 |
of the spike protein | 118 |
was found to be | 117 |
the kingdom of saudi | 117 |
the upper respiratory tract | 114 |
respiratory syndrome coronavirus disease | 113 |
respiratory syndrome coronavirus spike | 112 |
coronavirus in dromedary camels | 111 |
of patients infected with | 111 |
at the time of | 110 |
infection in dromedary camels | 109 |
in saudi arabia middle | 109 |
a systematic review and | 109 |
east respiratory syndrome in | 109 |
outbreak in the republic | 108 |
acute respiratory syndrome in | 108 |
an important role in | 108 |
respiratory syndrome coronavirus and | 107 |
has been shown to | 106 |
coronavirus middle east respiratory | 106 |
of critically ill patients | 106 |
human transmission of mers | 104 |
it is important to | 104 |
in the respiratory tract | 103 |
on the basis of | 103 |
from the middle east | 99 |
the emerging human coronavirus | 99 |
dipeptidyl peptidase is a | 99 |
of cases of middle | 98 |
peptidase is a functional | 98 |
for the emerging human | 98 |
receptor for the emerging | 98 |
in patients with covid | 97 |
antibodies in dromedary camels | 97 |
were found to be | 95 |
coronavirus disease from saudi | 95 |
vitro and in vivo | 95 |
syndrome coronavirus disease from | 95 |
disease from saudi arabia | 95 |
a l p r | 94 |
p r o o | 94 |
u r n a | 94 |
o u r n | 94 |
l p r e | 94 |
n a l p | 94 |
r o o f | 94 |
j o u r | 94 |
r n a l | 94 |
of the novel coronavirus | 94 |
the united arab emirates | 92 |
as a result of | 92 |
in addition to the | 92 |
infection with middle east | 91 |
have been shown to | 91 |
camels in saudi arabia | 89 |
associated with acute respiratory | 89 |
the s protein of | 88 |
transmission of mers coronavirus | 87 |
the mers outbreak in | 87 |
isolation and characterization of | 86 |
modified vaccinia virus ankara | 86 |
systematic review and meta | 86 |
in the upper respiratory | 85 |
in the development of | 84 |
dromedary camels in saudi | 84 |
against middle east respiratory | 83 |
transcription polymerase chain reaction | 82 |
of the s protein | 81 |
porcine epidemic diarrhea virus | 81 |
the middle east and | 81 |
of the severe acute | 81 |
mers coronavirus in dromedary | 80 |
from patients with pneumonia | 80 |
a large number of | 80 |
of the novel human | 78 |
the spread of the | 78 |
influenza a h n | 78 |
transmission of middle east | 78 |
syndrome coronavirus spike protein | 77 |
in severe acute respiratory | 77 |
in saudi arabia in | 76 |
a retrospective cohort study | 76 |
in the kingdom of | 76 |
caused by a novel | 75 |
one of the most | 75 |
ill patients with middle | 75 |
cluster of middle east | 74 |
clinical features of patients | 73 |
mers outbreak in korea | 73 |
study middle east respiratory | 72 |
for severe acute respiratory | 72 |
respiratory distress syndrome in | 72 |
is one of the | 72 |
a wide range of | 72 |
at the end of | 71 |
family cluster of middle | 71 |
the total number of | 71 |
have been reported to | 71 |
identification of a novel | 71 |
infected with novel coronavirus | 71 |
a systematic review of | 71 |
during the mers outbreak | 70 |
cov outbreak in south | 70 |
patients infected with novel | 69 |
with novel coronavirus in | 69 |
in the number of | 69 |
features of patients infected | 68 |
for the detection of | 68 |
syndrome coronavirus in dromedary | 68 |
of novel coronavirus pneumonia | 67 |
transmission of the virus | 67 |
course and outcomes of | 67 |
of the sars coronavirus | 67 |
clinical course and outcomes | 67 |
coronavirus infection in dromedary | 67 |
lower respiratory tract infection | 67 |
a novel human coronavirus | 66 |
serum antibodies in dromedary | 66 |
in the lower respiratory | 66 |
as well as in | 66 |
coronavirus in saudi arabia | 66 |
a mouse model for | 66 |
of hospitalized patients with | 66 |
a comparative serological study | 66 |
in the spike protein | 65 |
as shown in figure | 65 |
outcomes of critically ill | 65 |
to severe acute respiratory | 65 |
play an important role | 65 |
cov infection in a | 64 |
by a novel coronavirus | 64 |
and outcomes of critically | 64 |
with the middle east | 64 |
of a case of | 63 |
can be used to | 63 |
been shown to be | 63 |
novel coronavirus in wuhan | 62 |
coronavirus neutralising serum antibodies | 62 |
respiratory syndrome coronavirus neutralising | 62 |
neutralising serum antibodies in | 62 |
middle eastern respiratory syndrome | 62 |
syndrome coronavirus neutralising serum | 62 |
in saudi arabia and | 61 |
outbreak of severe acute | 61 |
patients with severe covid | 61 |
the end of the | 61 |
to middle east respiratory | 61 |
to the middle east | 60 |
have been reported in | 60 |
on the surface of | 60 |
of sars and mers | 60 |
efficacy and safety of | 60 |
confirmed cases of mers | 60 |
syndrome coronavirus middle east | 59 |
has been reported to | 59 |
the innate immune response | 59 |
the receptor binding domain | 59 |
patients with pneumonia in | 59 |
saudi ministry of health | 59 |
similar to that of | 59 |
at the same time | 59 |
coronavirus from patients with | 59 |
novel coronavirus from patients | 59 |
in the present study | 59 |
the development of a | 59 |
respiratory syndrome coronavirus middle | 59 |
and characterization of a | 58 |
of a novel human | 58 |
during the course of | 58 |
genomic characterization of a | 58 |
in middle east respiratory | 58 |
in vero e cells | 58 |
of the virus in | 58 |
with pneumonia in china | 58 |
studies have shown that | 58 |
in a mouse model | 57 |
the intensive care unit | 57 |
treatment of severe acute | 57 |
inflammatory cytokines and chemokines | 57 |
for the first time | 56 |
with the novel coronavirus | 56 |
entry into host cells | 56 |
h n influenza virus | 56 |
and epidemiology of novel | 56 |
human betacoronavirus c emc | 56 |
no conflict of interest | 56 |
the treatment of sars | 56 |
epidemiology of novel coronavirus | 56 |
a novel coronavirus in | 56 |
it is possible that | 56 |
for critically ill patients | 55 |
for virus origins and | 55 |
a newly discovered coronavirus | 55 |
human middle east respiratory | 55 |
with a new coronavirus | 55 |
coronavirus in patients with | 55 |
cases of infection with | 55 |
outcomes of patients with | 55 |
implications for virus origins | 55 |
severe middle east respiratory | 55 |
respiratory tract infection in | 54 |
cases have been reported | 54 |
virus origins and receptor | 54 |
the coronavirus study group | 54 |
coronavirus infection in the | 54 |
were more likely to | 54 |
outbreak associated with a | 54 |
origins and receptor binding | 54 |
for the presence of | 54 |
patients infected with sars | 54 |
of a newly discovered | 53 |
spread of the virus | 53 |
who has granted medrxiv | 53 |
discovered coronavirus associated with | 53 |
characterisation and epidemiology of | 53 |
a license to display | 53 |
cov outbreak in jeddah | 53 |
to health care facilities | 53 |
distress syndrome in humans | 53 |
the human respiratory tract | 53 |
of probable bat origin | 53 |
a new coronavirus of | 53 |
link to health care | 53 |
newly discovered coronavirus associated | 53 |
spike protein of sars | 53 |
the treatment of severe | 53 |
pneumonia outbreak associated with | 53 |
coronavirus of probable bat | 53 |
medrxiv a license to | 53 |
display the preprint in | 53 |
granted medrxiv a license | 53 |
a pneumonia outbreak associated | 53 |
license to display the | 53 |
treatment of middle east | 53 |
the onset of symptoms | 53 |
the authors declare that | 53 |
center for disease control | 53 |
associated with a new | 53 |
to display the preprint | 53 |
has granted medrxiv a | 53 |
respiratory syndrome coronavirus replication | 53 |
coronavirus associated with acute | 53 |
new coronavirus of probable | 53 |
by the world health | 52 |
a link to health | 52 |
characterization of a newly | 52 |
genomic characterisation and epidemiology | 52 |
the binding of the | 52 |
respiratory syndrome coronavirus as | 52 |
upper and lower respiratory | 52 |
novel coronavirus associated with | 51 |
cause of severe acute | 51 |
of patients with covid | 51 |
camels middle east respiratory | 51 |
model for middle east | 51 |
the spread of mers | 51 |
the role of the | 50 |
patients with novel coronavirus | 50 |
a case of middle | 50 |
the case fatality rate | 50 |
and severe acute respiratory | 50 |
against mers coronavirus in | 50 |
the first case of | 50 |
binding domain complexed with | 50 |
the authors declare no | 50 |
antibodies against mers coronavirus | 50 |
cases of novel coronavirus | 50 |
a novel coronavirus associated | 49 |
in balb c mice | 49 |
cd and cd t | 49 |
and cd t cells | 49 |
as the gene source | 49 |
east respiratory syndrome outbreak | 49 |
respiratory syndrome coronavirus transmission | 49 |
has been reported in | 49 |
of convalescent plasma therapy | 49 |
s protein of sars | 49 |
the course of the | 49 |
the gene source of | 49 |
in patients with middle | 48 |
in patients infected with | 48 |
and virological analysis of | 48 |
analysis of a case | 48 |
these results suggest that | 48 |
in critically ill patients | 48 |
after the onset of | 48 |
in upper respiratory tract | 48 |
and evolution of the | 48 |
clinical features and virological | 48 |
cov infection in dromedary | 48 |
of patients with severe | 48 |
virological analysis of a | 48 |
of the coronavirus study | 48 |
epidemiological and clinical characteristics | 48 |
and the middle east | 48 |
important role in the | 48 |
features and virological analysis | 48 |
this work was supported | 48 |
and cellular immune responses | 47 |
patients with coronavirus disease | 47 |
there is no evidence | 47 |
work was supported by | 47 |
cytokines and chemokines in | 47 |
respiratory syndrome coronavirus by | 47 |
to the world health | 47 |
are more likely to | 47 |
korea middle east respiratory | 47 |
to better understand the | 47 |
detection of a novel | 47 |
outbreaks of middle east | 47 |
the efficacy and safety | 47 |
novel middle east respiratory | 46 |
patients infected with the | 46 |
novel coronavirus pneumonia in | 46 |
the preprint in perpetuity | 46 |
crystal structure of the | 46 |
respiratory syndrome in hong | 46 |
used in this study | 46 |
syndrome in hong kong | 46 |
coronaviruses as the gene | 46 |
the presence of mers | 46 |
korea centers for disease | 46 |
the basic reproduction number | 46 |
syndrome coronavirus in bats | 46 |
the saudi ministry of | 46 |
a nonhuman primate model | 46 |
in a nonhuman primate | 46 |
and shortness of breath | 46 |
infection in the united | 45 |
and lower respiratory tract | 45 |
to be associated with | 45 |
syndrome middle east respiratory | 45 |
for the prevention of | 45 |
dromedary camels middle east | 45 |
the early stage of | 45 |
in the common marmoset | 45 |
the copyright holder for | 45 |
influenza a and b | 45 |
coronavirus associated with severe | 45 |
novel human coronavirus by | 45 |
of the mers outbreak | 44 |
of cases of novel | 44 |
cov infection in humans | 44 |
the number of cases | 44 |
coronavirus pneumonia in wuhan | 44 |
was supported by the | 44 |
in the human population | 44 |
of novel human coronavirus | 44 |
copyright holder for this | 44 |
rna was detected in | 44 |
the antiviral activity of | 44 |
diagnosis and treatment of | 44 |
and the number of | 44 |
binding domain of mers | 44 |
that they have no | 44 |
associated with severe acute | 44 |
declare that they have | 44 |
respiratory syndrome middle east | 44 |
case fatality rate of | 44 |
a potent inhibitor of | 44 |
was detected in the | 44 |
respiratory syndrome coronavirus outbreak | 44 |
the host immune response | 44 |
orf a and orf | 44 |
our understanding of the | 44 |
the case of sars | 44 |
infection in rhesus macaques | 44 |
upper respiratory tract of | 43 |
de wit et al | 43 |
of human middle east | 43 |
nonhuman primate model of | 43 |
ribavirin and interferon therapy | 43 |
entry depends on ace | 43 |
a fatal case of | 43 |
complete genome sequence of | 43 |
it has been reported | 43 |
cell entry depends on | 43 |
depends on ace and | 43 |
in the lungs and | 43 |
respiratory illness caused by | 43 |
and is blocked by | 43 |
of the virus and | 43 |
have been associated with | 43 |
the s subunit of | 43 |
is blocked by a | 43 |
novel coronavirus in patients | 43 |
blocked by a clinically | 43 |
a better understanding of | 43 |
respiratory syndrome coronavirus papain | 43 |
the spike glycoprotein of | 43 |
ace and tmprss and | 42 |
ribavirin and interferon alfa | 42 |
binding domain of the | 42 |
authors declare that they | 42 |
of novel coronavirus in | 42 |
receptor for the sars | 42 |
on ace and tmprss | 42 |
syndrome coronavirus in saudi | 42 |
for severe middle east | 42 |
the results of the | 42 |
associated with the novel | 42 |
human coronavirus by real | 42 |
play a role in | 42 |
from a patient with | 42 |
the early stages of | 42 |
as shown in fig | 42 |
and tmprss and is | 42 |
in patients with mers | 42 |
tmprss and is blocked | 42 |
of influenza a virus | 41 |
international committee on taxonomy | 41 |
plays an important role | 41 |
by a clinically proven | 41 |
of infection with middle | 41 |
respiratory syndrome coronavirus vaccine | 41 |
in the united arab | 41 |
the novel human betacoronavirus | 41 |
and postexposure efficacy of | 41 |
of patients with mers | 41 |
syndrome coronavirus infection and | 41 |
replication of middle east | 41 |
eastern respiratory syndrome coronavirus | 41 |
national institutes of health | 41 |
in patients with sars | 41 |
committee on taxonomy of | 41 |
has been reported that | 41 |
a clinically proven protease | 41 |
food and drug administration | 40 |
in the healthcare setting | 40 |
novel human coronavirus mers | 40 |
cov in upper respiratory | 40 |
viral rna was detected | 40 |
with a combination of | 40 |
to the lack of | 40 |
of viral rna in | 40 |
remdesivir and chloroquine effectively | 40 |
the recently emerged novel | 40 |
the incubation period of | 40 |
and outcomes of patients | 40 |
safety and efficacy of | 40 |
a total of patients | 40 |
human infection with mers | 40 |
innate and adaptive immune | 40 |
associated outbreak of middle | 40 |
from sars to mers | 40 |
pp a and pp | 40 |
recently emerged novel coronavirus | 40 |
and chloroquine effectively inhibit | 40 |
the sars and mers | 40 |
on taxonomy of viruses | 40 |
the centers for disease | 40 |
chloroquine effectively inhibit the | 40 |
clinically proven protease inhibitor | 40 |
it should be noted | 40 |
inhibit the recently emerged | 40 |
treatment with lopinavir ritonavir | 40 |
of patients with middle | 40 |
for the sars coronavirus | 40 |
effectively inhibit the recently | 40 |
of two cases of | 39 |
coronaviruses in dromedary camels | 39 |
of a mouse model | 39 |
for patients with middle | 39 |
the arabian peninsula and | 39 |
report of nosocomial transmission | 39 |
two cases of infection | 39 |
the respiratory tract of | 39 |
respiratory syndrome in the | 39 |
isolated from a patient | 39 |
a report of nosocomial | 39 |
features and viral diagnosis | 39 |
the fact that the | 39 |
of patients with sars | 39 |
rapid generation of a | 39 |
clinical features and viral | 39 |
syndrome coronavirus in the | 39 |
respiratory syndrome coronavirus a | 39 |
evolution of the middle | 39 |
presence or absence of | 39 |
on the use of | 39 |
diagnosis of two cases | 39 |
clinical characteristics of hospitalized | 39 |
sars and mers coronaviruses | 39 |
neutralizing antibodies against mers | 39 |
characteristics of hospitalized patients | 39 |
the pathogenesis of sars | 39 |
viral diagnosis of two | 39 |
of mouse hepatitis virus | 39 |
a randomized controlled trial | 39 |
for laboratory confirmation of | 39 |
enzyme is a functional | 39 |
and viral diagnosis of | 39 |
case of novel coronavirus | 38 |
in the management of | 38 |
coronavirus after exposure to | 38 |
a and orf b | 38 |
inhibitors of middle east | 38 |
the beginning of the | 38 |
with mers coronavirus after | 38 |
primate model of common | 38 |
is the author funder | 38 |
infection with mers coronavirus | 38 |
a case fatality rate | 38 |
mers coronavirus after exposure | 38 |
assays for laboratory confirmation | 38 |
increase the risk of | 38 |
hospitalized patients with novel | 38 |
in the transmission of | 38 |
a high prevalence of | 38 |
in the pathogenesis of | 38 |
after exposure to infected | 38 |
in a patient with | 38 |
the context of the | 38 |
characterization of a novel | 38 |
as severe acute respiratory | 38 |
mediated by the viral | 38 |
exposure to infected camels | 38 |
discovery and therapeutic options | 38 |
hospital in saudi arabia | 38 |
of the immune system | 38 |
generation of a mouse | 38 |
the crystal structure of | 38 |
of this study was | 38 |
coronavirus in household contacts | 38 |
a mortality rate of | 38 |
reported in saudi arabia | 38 |
transient lower respiratory tract | 37 |
recent insights into emerging | 37 |
in combination with ribavirin | 37 |
respiratory syndrome coronavirus receptor | 37 |
knowledge and data gaps | 37 |
coronavirus in dromedary camel | 37 |
have been detected in | 37 |
and data gaps of | 37 |
the treatment of mers | 37 |
model of common marmoset | 37 |
to that of sars | 37 |
a role in the | 37 |
replication and shedding of | 37 |
of knowledge and data | 37 |
the severity of the | 37 |
laboratory confirmation of novel | 37 |
by severe acute respiratory | 37 |
syndrome coronavirus outbreak in | 37 |
ribavirin improves outcome in | 37 |
a and pp ab | 37 |
from dromedary camels in | 37 |
the ministry of health | 37 |
confirmation of novel human | 37 |
therapeutic efficacy of remdesivir | 37 |
state of knowledge and | 37 |
a family cluster of | 37 |
mouse model for middle | 37 |
of the s subunit | 37 |
in close contact with | 37 |
and shedding of mers | 37 |
in accordance with the | 37 |
gaps of middle east | 37 |
data gaps of middle | 37 |
a for severe middle | 37 |
model of middle east | 37 |
of ebola virus disease | 37 |
b and ribavirin improves | 37 |
and ribavirin improves outcome | 37 |
insights into emerging coronaviruses | 37 |
the risk of mers | 37 |
improves outcome of mers | 37 |
improves outcome in mers | 37 |
mouse model of mers | 37 |
during the outbreak in | 37 |
use of convalescent plasma | 37 |
response in patients with | 37 |
mouse model of middle | 37 |
respiratory syndrome coronavirus antibodies | 37 |
holder for this preprint | 37 |
b improves outcome of | 36 |
article is protected by | 36 |
ministry of health and | 36 |
there is an urgent | 36 |
it is necessary to | 36 |
during the sars outbreak | 36 |
origin and evolution of | 36 |
for the middle east | 36 |
infection in a nonhuman | 36 |
is protected by copyright | 36 |
of a family cluster | 36 |
of the virus to | 36 |
with lopinavir ritonavir or | 36 |
in the form of | 36 |
due to the lack | 36 |
is consistent with the | 36 |
syndrome coronavirus antibodies in | 36 |
announcement of the coronavirus | 36 |
a combination of interferon | 36 |
a total of cases | 36 |
from the arabian peninsula | 36 |
a broad range of | 36 |
at room temperature for | 36 |
tested positive for mers | 36 |
on the epidemiology of | 36 |
illness caused by a | 36 |
should be noted that | 36 |
human airway epithelial cells | 36 |
this article is protected | 36 |
by a combination of | 36 |
em structure of the | 36 |
studies are needed to | 36 |
in chinese horseshoe bats | 36 |
the presence of the | 35 |
drug discovery and therapeutic | 35 |
syndrome coronavirus infections in | 35 |
a member of the | 35 |
of a fatal case | 35 |
associated with middle east | 35 |
with the exception of | 35 |
from animals to humans | 35 |
a middle east respiratory | 35 |
was first reported in | 35 |
chinese center for disease | 35 |
pipistrellus bat coronavirus hku | 35 |
more likely to be | 35 |
lopinavir ritonavir or interferon | 35 |
is closely related to | 35 |
the first imported case | 35 |
to that of the | 35 |
it was found that | 35 |
the early phase of | 35 |
the international committee on | 35 |
with the use of | 35 |
from a dromedary camel | 35 |
the novel middle east | 35 |
have the potential to | 35 |
and pathogenesis of coronaviruses | 35 |
severe acute respiratory infections | 35 |
middle east respiratory coronavirus | 35 |
experience in saudi arabia | 34 |
of coronavirus disease in | 34 |
coronavirus isolated from a | 34 |
may be due to | 34 |
interferon beta against mers | 34 |
coronavirus neutralizing antibodies in | 34 |
remdesivir and combination lopinavir | 34 |
causes transient lower respiratory | 34 |
the emergence of mers | 34 |
a public health emergency | 34 |
at the beginning of | 34 |
of mers coronavirus from | 34 |
as shown in table | 34 |
novel coronavirus in the | 34 |
three camel coronavirus species | 34 |
it is difficult to | 34 |
review of the literature | 34 |
aspects and outcomes of | 34 |
cells were transfected with | 34 |
efficacy of remdesivir and | 34 |
coronavirus outbreak in the | 34 |
and interferon beta against | 34 |
is an urgent need | 34 |
respiratory syndrome coronavirus from | 34 |
the importance of the | 34 |
coronavirus species and recombination | 34 |
tract infection in rhesus | 34 |
covs in saudi arabia | 34 |
of remdesivir and combination | 34 |
in any of the | 34 |
of three camel coronavirus | 34 |
have also been reported | 34 |
of the viral genome | 34 |
born to mothers with | 34 |
severe acute respiratory infection | 34 |
a h n virus | 34 |
clinical aspects and outcomes | 34 |
infected pneumonia in wuhan | 34 |
been reported to be | 34 |
prevalence of middle east | 34 |
respiratory syndrome corona virus | 34 |
and recombination of mers | 34 |
camel coronavirus species and | 34 |
the outbreak of sars | 34 |
the virus in the | 34 |
the causative agent of | 34 |
isolation of mers coronavirus | 34 |
converting enzyme is a | 34 |
species and recombination of | 34 |
a report of cases | 33 |
early transmission dynamics in | 33 |
basis of binding between | 33 |
and risk factors for | 33 |
dromedary camels in egypt | 33 |
and its receptor cd | 33 |
are summarized in table | 33 |
familial cluster of pneumonia | 33 |
as one of the | 33 |
pneumonia associated with the | 33 |
a broad spectrum of | 33 |
the novel coronavirus indicating | 33 |
uses the ace receptor | 33 |
in a recent study | 33 |
the highest number of | 33 |
mechanism of action of | 33 |
of the innate immune | 33 |
related to the sars | 33 |
mers coronaviruses in dromedary | 33 |
the use of corticosteroids | 33 |
be due to the | 33 |
in response to the | 33 |
the emergence of the | 33 |
macaque model of mers | 33 |
coronavirus infection and disease | 33 |
acute respiratory syndrome and | 33 |
disease prevention and control | 33 |
of pneumonia associated with | 33 |
structural and accessory proteins | 33 |
the national institutes of | 33 |
the transmission of mers | 33 |
a familial cluster of | 33 |
study of a family | 33 |
a single dose of | 33 |
was added to the | 33 |
transmission dynamics in wuhan | 33 |
testing for middle east | 33 |
a key role in | 33 |
parts of the world | 33 |
was used as the | 33 |
comparative therapeutic efficacy of | 33 |
be explained by the | 33 |
was used as a | 33 |
circulation of three camel | 33 |
a study of a | 33 |
the s protein is | 33 |
molecular basis of binding | 33 |
was approved by the | 33 |
imported case of middle | 33 |
cluster of pneumonia associated | 33 |
rhesus macaque model of | 33 |
and approved the final | 32 |
inhibits both epidemic and | 32 |
was not associated with | 32 |
assays reveal a high | 32 |
high prevalence of antibody | 32 |
potential conflicts of interest | 32 |
used for the treatment | 32 |
of antibody in dromedary | 32 |
type i interferon production | 32 |
prevalence of antibody in | 32 |
emergency of international concern | 32 |
antibodies in saudi arabia | 32 |
have been identified in | 32 |
for patients with severe | 32 |
replication in cell culture | 32 |
severity of the disease | 32 |
has been found to | 32 |
presence of middle east | 32 |
mortality in patients with | 32 |
the treatment of patients | 32 |
of the immune response | 32 |
coronavirus antibodies in saudi | 32 |
entry into the host | 32 |
reveal a high prevalence | 32 |
protein of middle east | 32 |
seroepidemiology for mers coronavirus | 32 |
high morbidity and mortality | 32 |
in the s protein | 32 |
is likely to be | 32 |
spread of the disease | 32 |
or in combination with | 32 |
cellular immune responses in | 32 |
first case of novel | 32 |
the s and s | 32 |
can be found in | 32 |
cov and its receptor | 32 |
antibody in dromedary camels | 32 |
severe respiratory illness caused | 32 |
is mediated by the | 32 |
of binding between novel | 32 |
in jeddah and riyadh | 32 |
similar to those of | 32 |
binding between novel human | 32 |
between novel human coronavirus | 32 |
it has been shown | 32 |
reported to the world | 32 |
we would like to | 32 |
infection control and prevention | 32 |
both epidemic and zoonotic | 32 |
epidemic and zoonotic coronaviruses | 32 |
in dromedary camel herd | 32 |
would like to thank | 32 |
for mers coronavirus using | 32 |
of a new human | 32 |
type i and type | 32 |
mers outbreak in south | 31 |
number of confirmed cases | 31 |
investigation middle east respiratory | 31 |
syndrome coronavirus in bat | 31 |
in the prefusion conformation | 31 |
related viruses in bats | 31 |
characterization of a bat | 31 |
relative of human middle | 31 |
were included in the | 31 |
mers coronavirus using microneutralisation | 31 |
the national institute of | 31 |
are likely to be | 31 |
close relative of human | 31 |
the presence or absence | 31 |
safety and immunogenicity of | 31 |
virus was detected in | 31 |
an outbreak of middle | 31 |
that uses the ace | 31 |
the epidemiology of mers | 31 |
therapy for critically ill | 31 |
identification and characterization of | 31 |
microneutralisation and pseudoparticle virus | 31 |
is associated with a | 31 |
health emergency of international | 31 |
causes lethal pneumonia in | 31 |
for sars and mers | 31 |
coronavirus using microneutralisation and | 31 |
a descriptive genomic study | 31 |
infection middle east respiratory | 31 |
the emergence of sars | 31 |
a randomized clinical trial | 31 |
the basis of the | 31 |
using microneutralisation and pseudoparticle | 31 |
a possible cause of | 31 |
transmissibility of middle east | 31 |
to be the most | 31 |
for the study of | 31 |
the central nervous system | 31 |
respiratory syndrome coronavirus pneumonia | 31 |
as well as a | 31 |
respiratory syndrome coronavirus mers | 31 |
of a bat sars | 31 |
coronavirus that uses the | 31 |
these results indicate that | 31 |
the rhesus macaque model | 31 |
in this study were | 31 |
prevention and control measures | 31 |
public health emergency of | 31 |
this study was to | 31 |
of the risk of | 31 |
there was no significant | 31 |
upper respiratory tract infections | 31 |
at a concentration of | 31 |
center experience in saudi | 31 |
days after symptom onset | 31 |
in the course of | 31 |
and pseudoparticle virus neutralisation | 30 |
was first identified in | 30 |
the results showed that | 30 |
allergy and infectious diseases | 30 |
cells were infected with | 30 |
in the rhesus macaque | 30 |
it has also been | 30 |
virus neutralisation assays reveal | 30 |
neutralisation assays reveal a | 30 |
humoral and cellular immune | 30 |
lethal pneumonia in the | 30 |
pneumonia in the common | 30 |
and evolution of pathogenic | 30 |
min at room temperature | 30 |
livestock in saudi arabia | 30 |
in the early stage | 30 |
respiratory syndrome in a | 30 |
international severe acute respiratory | 30 |
like coronavirus that uses | 30 |
uenza a h n | 30 |
days after the onset | 30 |
evolution of pathogenic coronaviruses | 30 |
as a possible cause | 30 |
in vitro antiviral activity | 30 |
treatment of patients with | 30 |
for disease prevention and | 30 |
a descriptive study clinical | 30 |
of angiotensin converting enzyme | 30 |
the outbreak of mers | 30 |
infl uenza a h | 30 |
to the fact that | 30 |
these findings suggest that | 30 |
coronavirus as a possible | 30 |
the majority of the | 30 |
of allergy and infectious | 30 |
of mers and sars | 30 |
better understanding of the | 30 |
possible cause of severe | 30 |
lower respiratory tract infections | 30 |
mers coronavirus from a | 30 |
and phylogenetic analysis of | 30 |
pseudoparticle virus neutralisation assays | 30 |
coronavirus from a dromedary | 30 |
a mouse model of | 30 |
respiratory syndrome coronavirus fusion | 30 |
closely related to the | 30 |
of inflammatory cytokines and | 30 |
cov causes lethal pneumonia | 30 |
the outbreak in the | 30 |
mers outbreak in the | 30 |
the origin of the | 30 |
be one of the | 30 |
have no competing interests | 29 |
respiratory syndrome coronavirus the | 29 |
been found to be | 29 |
activation of the spike | 29 |
is responsible for the | 29 |
has been detected in | 29 |
with human receptor dpp | 29 |
to the development of | 29 |
at the university of | 29 |
emergence of a novel | 29 |
upper respiratory tract and | 29 |
host cell entry of | 29 |
a combination of lopinavir | 29 |
human neutralizing monoclonal antibodies | 29 |
coronavirus in the united | 29 |
and characterization of viruses | 29 |
of emerging infectious diseases | 29 |
on the arabian peninsula | 29 |
respiratory tract infections in | 29 |
of viruses related to | 29 |
domestic livestock in saudi | 29 |
monoclonal antibody against mers | 29 |
coronavirus replication in cell | 29 |
of proinflammatory cytokines and | 29 |
domain complexed with human | 29 |
domain of the spike | 29 |
an intensive care unit | 29 |
patients with severe mers | 29 |
were observed in the | 29 |
complexed with human receptor | 29 |
prevent the spread of | 29 |
and the risk of | 29 |
structural basis for the | 29 |
of lopinavir ritonavir in | 29 |
of the number of | 29 |
to the emergence of | 29 |
a major role in | 29 |
the innate immune system | 29 |
into the host cell | 29 |
novel coronavirus indicating person | 29 |
seroprevalence in domestic livestock | 29 |
in domestic livestock in | 29 |
risk factors for primary | 29 |
they have no competing | 29 |
alone or in combination | 29 |
n and h n | 29 |
increase in the number | 29 |
the spread of covid | 29 |
h n and h | 29 |
declare no conflict of | 29 |
exposure in an emergency | 29 |
from middle east respiratory | 29 |
virus in chinese horseshoe | 29 |
the institutional review board | 29 |
and clinical features of | 28 |
epidemiology of middle east | 28 |
primary middle east respiratory | 28 |
and the pathogenesis of | 28 |
centre for disease prevention | 28 |
during the outbreak of | 28 |
from animals in southern | 28 |
those who did not | 28 |
authors declare no conflict | 28 |
are shown in table | 28 |
single patient exposure in | 28 |
risk factors for middle | 28 |
the sars coronavirus spike | 28 |
of transmission of mers | 28 |
type i and ii | 28 |
confirmed cases of middle | 28 |
in health care workers | 28 |
entry of middle east | 28 |
interferon therapy in patients | 28 |
the sars coronavirus from | 28 |
estimation of pandemic risk | 28 |
prophylactic and therapeutic remdesivir | 28 |
characterization of viruses related | 28 |
coronavirus seroprevalence in domestic | 28 |
european centre for disease | 28 |
and interferon therapy in | 28 |
sars coronavirus from animals | 28 |
replication by a combination | 28 |
animals in southern china | 28 |
a single patient exposure | 28 |
has been shown that | 28 |
patient exposure in an | 28 |
syndrome coronavirus spike glycoprotein | 28 |
coronavirus open reading frame | 28 |
reduces virus excretion after | 28 |
an ic value of | 28 |
therapy in patients infected | 28 |
virus excretion after mers | 28 |
systematic review of treatment | 28 |
coronavirus disease in china | 28 |
has not yet been | 28 |
as compared to the | 28 |
humanized mouse model of | 28 |
were infected with mers | 28 |
coronavirus replication by a | 28 |
viruses related to the | 28 |
to the sars coronavirus | 28 |
of the incubation period | 28 |
more likely to have | 28 |
following a single patient | 28 |
has been used to | 28 |
to the arabian peninsula | 28 |
the transmission of the | 28 |
coronavirus from animals in | 28 |
in saudi arabia mers | 28 |
highly pathogenic avian influenza | 28 |
factors for middle east | 28 |
studies are required to | 28 |
for primary middle east | 28 |
threat to public health | 28 |
vaccine reduces virus excretion | 28 |
risk factors for mortality | 28 |
with respect to the | 28 |
the risk factors for | 28 |
interhuman transmissibility of middle | 28 |
infected with the middle | 28 |
outbreak of novel coronavirus | 28 |
the mechanism of action | 28 |
prevention and control of | 28 |
the pathogenesis of mers | 28 |
syndrome coronavirus infection during | 28 |
factors for primary middle | 28 |
hospitalized patients with covid | 27 |
in the emergency room | 27 |
in view of the | 27 |
the ability of the | 27 |
be used as a | 27 |
of personal protective equipment | 27 |
national institute of allergy | 27 |
and the presence of | 27 |
the average number of | 27 |
east respiratory syndrome middle | 27 |
was no significant difference | 27 |
in contrast to the | 27 |
respiratory syndrome coronavirus during | 27 |
pregnant women with covid | 27 |
syndrome coronavirus replication in | 27 |
as the number of | 27 |
syndrome coronavirus as a | 27 |
there have been no | 27 |
of fully human antibodies | 27 |
epithelial cells of the | 27 |
institute of allergy and | 27 |
cov infection in the | 27 |
national health commission of | 27 |
serology in major livestock | 27 |
innate immune response to | 27 |
also known as cd | 27 |
a high mortality rate | 27 |
the viral spike protein | 27 |
were found to have | 27 |
efficacy of fully human | 27 |
h n influenza a | 27 |
livestock species in an | 27 |
major livestock species in | 27 |
reverse transcription polymerase chain | 27 |
patients with acute respiratory | 27 |
of their replication and | 27 |
lower respiratory tract specimens | 27 |
chronic obstructive pulmonary disease | 27 |
cd t cells in | 27 |
the inhibitory activity of | 27 |
like virus in chinese | 27 |
is a potent inhibitor | 27 |
a review of the | 27 |
mice infected with mers | 27 |
study of hospitalized patients | 27 |
an affected region in | 27 |
pregnant women infected with | 27 |
in hospitalized patients with | 27 |
and acute respiratory distress | 27 |
in an affected region | 27 |
has been associated with | 27 |
into the host cells | 27 |
against severe acute respiratory | 27 |
of acute respiratory distress | 27 |
there is a need | 27 |
on the cell surface | 27 |
ncov spike in the | 27 |
characteristics of coronavirus disease | 27 |
review of treatment effects | 27 |
novel humanized mouse model | 27 |
with sars and mers | 27 |
spike in the prefusion | 27 |
progression to respiratory failure | 27 |
the emerging novel human | 27 |
the interaction between the | 27 |
clinical characteristics of coronavirus | 27 |
to the intensive care | 27 |
a novel humanized mouse | 27 |
affected region in jordan | 27 |
in a novel humanized | 27 |
rift valley fever virus | 27 |
in an emergency room | 27 |
species in an affected | 27 |
tertiary care hospital in | 27 |
of health and welfare | 27 |
specific human monoclonal antibody | 27 |
in major livestock species | 27 |
mers coronavirus neutralizing antibodies | 27 |
report of cases from | 27 |
in dromedary camels middle | 27 |
viral shedding and antibody | 27 |
and antibody response in | 26 |
little is known about | 26 |
with a case fatality | 26 |
in the human respiratory | 26 |
infected with middle east | 26 |
we found that the | 26 |
an overview of their | 26 |
syndrome coronavirus fusion inhibitor | 26 |
their replication and pathogenesis | 26 |
ultrastructural findings of a | 26 |
respiratory syncytial virus infection | 26 |
a new human coronavirus | 26 |
are not susceptible to | 26 |
a critical role in | 26 |
the immune response to | 26 |
tract of inoculated dromedary | 26 |
human antibodies against spike | 26 |
compared to those of | 26 |
geographic distribution of mers | 26 |
postexposure efficacy of fully | 26 |
and adaptive immune responses | 26 |
had a history of | 26 |
severe acute respiratory illness | 26 |
emergence of middle east | 26 |
antibody response in patients | 26 |
overview of their replication | 26 |
of the disease in | 26 |
was associated with a | 26 |
cov outbreak following a | 26 |
in the early stages | 26 |
the functional receptor for | 26 |
entry into target cells | 26 |
been reported to the | 26 |
an epidemiological outbreak study | 26 |
cases in saudi arabia | 26 |
this is the first | 26 |
pathological findings of covid | 26 |
a transgenic mouse model | 26 |
cells were washed with | 26 |
the chinese center for | 26 |
of an outbreak of | 26 |
early stage of the | 26 |
is shown in fig | 26 |
are potent inhibitors of | 26 |
may be related to | 26 |
no significant difference in | 26 |
protein in a novel | 26 |
of human coronavirus nl | 26 |
receptor binding domain of | 26 |
viral replication in the | 26 |
is thought to be | 26 |
of the spike glycoprotein | 26 |
have been used to | 26 |
spike protein in a | 26 |
the detection of mers | 26 |
the majority of cases | 26 |
lopinavir ritonavir in the | 26 |
against spike protein in | 26 |
outbreak following a single | 26 |
a median of days | 26 |
the cells were washed | 26 |
peripheral blood mononuclear cells | 26 |
an increased risk of | 26 |
clinical signs of disease | 26 |
for treatment of covid | 26 |
severe acute respiratory and | 26 |
antibodies against spike protein | 26 |
of inoculated dromedary camels | 26 |
characterization of the novel | 26 |
for min at room | 26 |
is considered to be | 26 |
these data suggest that | 26 |
transcriptase polymerase chain reaction | 26 |
prevention and treatment of | 26 |
in the united kingdom | 26 |
s f cd l | 26 |
fully human antibodies against | 26 |
of coronavirus spike proteins | 26 |
are considered to be | 26 |
respiratory tract of inoculated | 26 |
in combination with other | 26 |
shedding and antibody response | 26 |
the novel human coronavirus | 26 |
the development of vaccines | 26 |
the use of a | 26 |
respiratory distress syndrome and | 26 |
of viral shedding and | 26 |
findings of a fatal | 26 |
in line with the | 25 |
time reverse transcription pcr | 25 |
emergency room in south | 25 |
functional receptor for sars | 25 |
confirmed cases and deaths | 25 |
on the number of | 25 |
the sars outbreak in | 25 |
emerg infect dis doi | 25 |
the humoral immune response | 25 |
of lopinavir ritonavir and | 25 |
mers coronavirus infection in | 25 |
mediated activation of the | 25 |
preliminary epidemiological assessment of | 25 |
with atypical pneumonia after | 25 |
acute respiratory syndrome the | 25 |
syndrome coronavirus as an | 25 |
as part of the | 25 |
laboratory testing for middle | 25 |
declare no competing interests | 25 |
the number of infected | 25 |
in terms of the | 25 |
a patient with atypical | 25 |
in an animal model | 25 |
early phase of the | 25 |
does not result in | 25 |
pneumonia after visiting wuhan | 25 |
of the arabian peninsula | 25 |
genomic characterization of the | 25 |
the s proteins of | 25 |
was observed in the | 25 |
the replication of sars | 25 |
in health care settings | 25 |
epidemiological assessment of mers | 25 |
the novel coronavirus from | 25 |
alphacoronavirus and betacoronavirus and | 25 |
ritonavir in the treatment | 25 |
induction of inflammatory cytokines | 25 |
respiratory syndrome coronavirus entry | 25 |
than that of sars | 25 |
in adults hospitalized with | 25 |
convalescent plasma therapy in | 25 |
of human coronavirus oc | 25 |
the structure of the | 25 |
mers coronavirus among dromedary | 25 |
coronavirus in jeddah and | 25 |
article can be found | 25 |
south korea middle east | 25 |
in a study of | 25 |
of the disease and | 25 |
ill patients with covid | 25 |
to be effective against | 25 |
identified in saudi arabia | 25 |
and the cells were | 25 |
novel human betacoronavirus c | 25 |
made available under a | 25 |
it is unclear whether | 25 |
transgenic mice infected with | 25 |
d g and i | 25 |
stability of middle east | 25 |
by the severe acute | 25 |
high case fatality rate | 25 |
novel human coronavirus emc | 25 |
by human monoclonal antibodies | 25 |
study of outbreaks of | 25 |
the case of the | 25 |
in the range of | 25 |
fatal case of middle | 25 |
the species severe acute | 25 |
coronavirus among dromedary camels | 25 |
in the majority of | 25 |
transmission characteristics of mers | 25 |
of mers coronavirus among | 25 |
emerging middle east respiratory | 25 |
the absence of a | 25 |
room in south korea | 25 |
this article can be | 25 |
cells were incubated with | 25 |
virus isolated from the | 25 |
outside the middle east | 25 |
a wide variety of | 25 |
and the development of | 25 |
species severe acute respiratory | 25 |
discovery of a novel | 25 |
an emergency room in | 25 |
avian infectious bronchitis virus | 25 |
atypical pneumonia after visiting | 25 |
patient with atypical pneumonia | 25 |
and the use of | 25 |
was not detected in | 25 |
animal model of mers | 25 |
immune responses in mice | 25 |
distribution of mers coronavirus | 25 |
g and i t | 25 |
acute respiratory and emerging | 25 |
from bench to bedside | 25 |
in vitro activity against | 24 |
hospitalized with severe covid | 24 |
number of secondary cases | 24 |
and naming it sars | 24 |
in the general population | 24 |
identification of a new | 24 |
were detected in the | 24 |
the genus deltacoronavirus supports | 24 |
combination with ribavirin to | 24 |
regard to jurisdictional claims | 24 |
mammalian and avian coronaviruses | 24 |
human to human transmission | 24 |
human monoclonal antibody protects | 24 |
by the novel coronavirus | 24 |
cell entry of middle | 24 |
on middle east respiratory | 24 |
gene source of gammacoronavirus | 24 |
the control of the | 24 |
were similar to those | 24 |
plays a role in | 24 |
east respiratory syndrome corona | 24 |
management of patients with | 24 |
the rest of the | 24 |
have been reported from | 24 |
was used for the | 24 |
genus deltacoronavirus supports bat | 24 |
risk factors for mers | 24 |
virological and clinical findings | 24 |
and chemokines in human | 24 |
initial virological and clinical | 24 |
effectiveness of convalescent plasma | 24 |
the risk of death | 24 |
in a single inoculum | 24 |
and avian coronaviruses in | 24 |
adults hospitalized with severe | 24 |
was not certified by | 24 |
a result of the | 24 |
not certified by peer | 24 |
source of gammacoronavirus and | 24 |
course of the disease | 24 |
syndrome coronavirus in jeddah | 24 |
is important to note | 24 |
in the intensive care | 24 |
and ultrastructural findings of | 24 |
a major outbreak of | 24 |
a severe acute respiratory | 24 |
to jurisdictional claims in | 24 |
jurisdictional claims in published | 24 |
are involved in the | 24 |
are similar to those | 24 |
by the fact that | 24 |
dromedary camels in the | 24 |
lower respiratory tract of | 24 |
sars in the healthcare | 24 |
with severe disease and | 24 |
is made available under | 24 |
treatment in the rhesus | 24 |
based vaccine reduces virus | 24 |
neutral with regard to | 24 |
seven novel mammalian and | 24 |
an urgent need for | 24 |
was shown to be | 24 |
ribavirin to treat middle | 24 |
characteristics of mers and | 24 |
is strongly inhibited by | 24 |
of porcine epidemic diarrhea | 24 |
of the cases were | 24 |
avian coronaviruses in the | 24 |
feline infectious peritonitis virus | 24 |
phase i clinical trial | 24 |
entry of the virus | 24 |
outbreak investigation middle east | 24 |
gene source of alphacoronavirus | 24 |
used in the treatment | 24 |
remains neutral with regard | 24 |
mers and sars in | 24 |
it is made available | 24 |
is based on the | 24 |
of outbreaks of middle | 24 |
another zoonotic betacoronavirus causing | 24 |
to sars and mers | 24 |
and betacoronavirus and avian | 24 |
the extent of the | 24 |
certified by peer review | 24 |
with regard to jurisdictional | 24 |
the safety and efficacy | 24 |
ncov and naming it | 24 |
human bronchial epithelial cells | 24 |
respiratory disease in humans | 24 |
of seven novel mammalian | 24 |
treat middle east respiratory | 24 |
novel mammalian and avian | 24 |
source of alphacoronavirus and | 24 |
coronaviruses in the genus | 24 |
an outbreak investigation middle | 24 |
the median incubation period | 24 |
in the early phase | 24 |
of alphacoronavirus and betacoronavirus | 24 |
which was not certified | 24 |
of the international committee | 24 |
the aim of this | 24 |
can be used as | 24 |
with ribavirin to treat | 24 |
outside the arabian peninsula | 24 |
patients with confirmed mers | 24 |
the presence of a | 24 |
in the genus deltacoronavirus | 24 |
the h n influenza | 24 |
recombinant modified vaccinia virus | 24 |
pathogenic coronavirus isolated from | 24 |
human immunodeficiency virus type | 24 |
there is no specific | 24 |
infections in health care | 24 |
control study of hospitalized | 24 |
coronavirus infectious bronchitis virus | 24 |
to treat middle east | 24 |
and sars in the | 24 |
cov cl pro and | 24 |
the presence of viral | 24 |
severe disease and death | 24 |
it is likely that | 23 |
role of lopinavir ritonavir | 23 |
associated middle east respiratory | 23 |
in the regulation of | 23 |
chemokines in human macrophages | 23 |
in published maps and | 23 |
is a type i | 23 |
the onset of the | 23 |
the structural and accessory | 23 |
avian coronaviruses as the | 23 |
s subunit of the | 23 |
in this study was | 23 |
severe in vitro cytopathology | 23 |
deltacoronavirus supports bat coronaviruses | 23 |
an animal model of | 23 |
approved the final manuscript | 23 |
in mice infected with | 23 |
neutralizing antibodies in camels | 23 |
rna was extracted from | 23 |
induces severe in vitro | 23 |
betacoronavirus and avian coronaviruses | 23 |
with fetal bovine serum | 23 |
supports bat coronaviruses as | 23 |
at the level of | 23 |
aberrant induction of inflammatory | 23 |
inhibits the replication of | 23 |
of the virus from | 23 |
guidance for the public | 23 |
mers in south korea | 23 |
and public health authorities | 23 |
reverse transcriptase polymerase chain | 23 |
approved by the institutional | 23 |
the number of confirmed | 23 |
has the potential to | 23 |
and avian coronaviruses as | 23 |
the one health concept | 23 |
avian influenza a h | 23 |
coronavirus illness in humans | 23 |
outcomes of middle east | 23 |
a high level of | 23 |
of sars coronavirus infection | 23 |
important to note that | 23 |
of novel coronavirus infections | 23 |
for the novel coronavirus | 23 |
upper respiratory tract infection | 23 |
has yet to be | 23 |
coronavirus infection middle east | 23 |
no conflicts of interest | 23 |
vitro cytopathology and is | 23 |
syndrome coronavirus illness in | 23 |
for up to days | 23 |
animal care and use | 23 |
a hospital outbreak of | 23 |
transmission and evolution of | 23 |
nature remains neutral with | 23 |
and the role of | 23 |
to be able to | 23 |
the number of mers | 23 |
compared to the control | 23 |
the antiviral effects of | 23 |
specific cd t cells | 23 |
the s domain of | 23 |
alpha b and ribavirin | 23 |
genome sequence of a | 23 |
maps and institutional affiliations | 23 |
and is strongly inhibited | 23 |
than that of the | 23 |
cytopathology and is strongly | 23 |
study was approved by | 23 |
with a history of | 23 |
syndrome coronavirus after two | 23 |
discovery of seven novel | 23 |
zoonotic betacoronavirus causing sars | 23 |
with a mortality rate | 23 |
distributed under the terms | 23 |
it is believed that | 23 |
implications for the origin | 23 |
and outcomes of middle | 23 |
the surface of the | 23 |
bat coronaviruses as the | 23 |
respiratory syndrome coronavirus illness | 23 |
the origin of sars | 23 |
ill patients with mers | 23 |
in the setting of | 23 |
and aberrant induction of | 23 |
published maps and institutional | 23 |
the development of an | 23 |
major outbreak of severe | 23 |
claims in published maps | 23 |
the case of mers | 23 |
screening of an fda | 23 |
countries in the middle | 23 |
us centers for disease | 23 |
the absence of any | 23 |
respiratory and emerging infection | 23 |
replication induces severe in | 23 |
was estimated to be | 23 |
and their role in | 23 |
springer nature remains neutral | 23 |
coronavirus replication induces severe | 23 |
such as severe acute | 23 |
an incubation period of | 23 |
a in combination with | 23 |
of a transgenic mouse | 23 |
a limited number of | 23 |
for the evaluation of | 23 |
in vitro cytopathology and | 23 |
new insights into the | 23 |
a small number of | 22 |
on sars and mers | 22 |
betacoronavirus lineage c viruses | 22 |
and innate immune responses | 22 |
human cases of mers | 22 |
was identified as the | 22 |
the duration of the | 22 |
a trial of lopinavir | 22 |
of gammacoronavirus and deltacoronavirus | 22 |
risk factors associated with | 22 |
can be divided into | 22 |
of acute respiratory infections | 22 |
of the first mers | 22 |
factors influencing disaster response | 22 |
the efficacy of the | 22 |
the identification of the | 22 |
inhibition of middle east | 22 |
of human coronavirus e | 22 |
and treatment of covid | 22 |
a retrospective review of | 22 |
cyclosporin a or interferon | 22 |
strongly inhibited by cyclosporin | 22 |
a community outbreak of | 22 |
this preprint this version | 22 |
the results of this | 22 |
studies have demonstrated that | 22 |
by the presence of | 22 |
number of cases in | 22 |
as a model for | 22 |
organ infection and the | 22 |
serological study middle east | 22 |
were negative for mers | 22 |
viral loads in the | 22 |
authors declare no competing | 22 |
with a range of | 22 |
for the origin of | 22 |
cells infected with mers | 22 |
respiratory syndrome coronavirus after | 22 |
at increased risk of | 22 |
in the sera of | 22 |
at high risk of | 22 |
of the fusion core | 22 |
the spike protein gene | 22 |
in comparison to the | 22 |
the large number of | 22 |
acute middle east respiratory | 22 |
contact with dromedary camels | 22 |
combination of lopinavir ritonavir | 22 |
the phylogenetic tree of | 22 |
the genome sequence of | 22 |
of the host immune | 22 |
based study of outbreaks | 22 |
with the development of | 22 |
drugs for treatment of | 22 |
coronavirus infection in humans | 22 |
sequence of a novel | 22 |
to the best of | 22 |
and guidance for the | 22 |
as soon as possible | 22 |
preprint this version posted | 22 |
and viral load in | 22 |
in dromedary camels and | 22 |
infection of rhesus macaques | 22 |
potent inhibitor of sars | 22 |
results showed that the | 22 |
it has been demonstrated | 22 |
that can be used | 22 |
been shown to inhibit | 22 |
the epidemiological characteristics of | 22 |
unrecognized asymptomatic or mild | 22 |
inhibited by cyclosporin a | 22 |
and emerging infection consortium | 22 |
cov pl pro was | 22 |
coronavirus spike protein by | 22 |
and reviewed the manuscript | 22 |
by cyclosporin a or | 22 |
the time of the | 22 |
a human monoclonal antibody | 22 |
multiple organ infection and | 22 |
of west nile virus | 22 |
a potential target for | 22 |
the emerging middle east | 22 |
for this preprint this | 22 |
report of two cases | 22 |
inhibits type i interferon | 22 |
structural studies of sars | 22 |
care and use committee | 22 |
a risk factor for | 22 |
length infectious cdna of | 22 |
that there is a | 22 |
transgenic mouse model of | 22 |
from symptom onset to | 22 |
samples were collected from | 22 |
has been demonstrated that | 22 |
of the creative commons | 22 |
in patients with coronavirus | 22 |
early stages of the | 22 |
is known about the | 22 |
for h at c | 22 |
the creative commons attribution | 22 |
a vital role in | 22 |
the development of novel | 22 |
to evaluate the efficacy | 22 |
a total of laboratory | 22 |
s and s subunits | 22 |
spike protein of the | 22 |
between the two groups | 22 |
infection and the pathogenesis | 22 |
license it is made | 21 |
implications for pathogenesis and | 21 |
kinetic analysis of viral | 21 |
global alert and response | 21 |
in dromedary camels from | 21 |
epidemiological findings from a | 21 |
in saudi arabia the | 21 |
of the index patient | 21 |
have been identified as | 21 |
were approved by the | 21 |
spectrum of disease severity | 21 |
severe acute respiratory distress | 21 |
the most common symptoms | 21 |
shedding and immunological responses | 21 |
analysis of viral shedding | 21 |
infection in south korea | 21 |
the life cycle of | 21 |
syndrome is associated with | 21 |
a tertiary care hospital | 21 |
asymptomatic or mild case | 21 |
syndrome coronavirus through its | 21 |
coronavirus infections related to | 21 |
findings from a retrospective | 21 |
sea urchin egg homogenate | 21 |
sars coronavirus spike protein | 21 |
human respiratory disease in | 21 |
novel coronavirus from wuhan | 21 |
mortality risk factors for | 21 |
of the extent of | 21 |
load in a community | 21 |
the lungs of the | 21 |
of rift valley fever | 21 |
in sars and mers | 21 |
an overview of the | 21 |
the molecular biology of | 21 |
care and use of | 21 |
the development of new | 21 |
human and camel mers | 21 |
in the face of | 21 |
a multiplicity of infection | 21 |
representing a broad spectrum | 21 |
lopinavir ritonavir and interferon | 21 |
to prevent the spread | 21 |
from a retrospective investigation | 21 |
is known to be | 21 |
of the novel middle | 21 |
s in supplementary material | 21 |
infections related to a | 21 |
bats are natural reservoirs | 21 |
detection of novel coronavirus | 21 |
immunological responses in mers | 21 |
of science and technology | 21 |
reduce the risk of | 21 |
it is known that | 21 |
host species restriction of | 21 |
mers patients representing a | 21 |
the potential risk of | 21 |
from camels to humans | 21 |
likely unrecognized asymptomatic or | 21 |
in south korea in | 21 |
in agreement with the | 21 |
ritonavir in adults hospitalized | 21 |
to a lesser extent | 21 |
in a community outbreak | 21 |
both in vitro and | 21 |
is associated with the | 21 |
patients representing a broad | 21 |
for the use of | 21 |
to acute respiratory distress | 21 |
analyses were performed using | 21 |
acute respiratory syndrome among | 21 |
of the first imported | 21 |
a likely unrecognized asymptomatic | 21 |
analysis based on decade | 21 |
active replication of middle | 21 |
related to a likely | 21 |
read and approved the | 21 |
the use of convalescent | 21 |
incubated for h at | 21 |
with an ic value | 21 |
detection of middle east | 21 |
and kinetic analysis of | 21 |
viral load in a | 21 |
coronavirus through its receptor | 21 |
also been shown to | 21 |
due to the high | 21 |
in south korea and | 21 |
cov nsp and nsp | 21 |
comparative and kinetic analysis | 21 |
species restriction of middle | 21 |
sars coronavirus infection and | 21 |
respiratory syndrome coronavirus through | 21 |
progression and viral load | 21 |
the viral polymerase and | 21 |
an analysis based on | 21 |
it was shown that | 21 |
the middle east region | 21 |
clinical progression and viral | 21 |
performed as previously described | 21 |
to a likely unrecognized | 21 |
structure of the sars | 21 |
spike glycoprotein of the | 21 |
international license it is | 21 |
a and b viruses | 21 |
generation of a transgenic | 21 |
van doremalen et al | 21 |
immunopathology on challenge with | 21 |
admission to the icu | 21 |
broad spectrum of disease | 21 |
syndrome coronavirus and aberrant | 21 |
or acute respiratory distress | 21 |
long structural studies of | 21 |
the effect of the | 21 |
of the respiratory tract | 21 |
and immunological responses in | 21 |
for the diagnosis of | 21 |
risk of transmission of | 21 |
care hospital in saudi | 21 |
syndrome coronavirus infections related | 21 |
there are currently no | 21 |
coronavirus and aberrant induction | 21 |
a significant role in | 21 |
of probable sars cases | 21 |
higher than that of | 21 |
in the past years | 21 |
in light of the | 21 |
management of severe acute | 21 |
the analysis of the | 21 |
responses in mers patients | 21 |
summary and literature update | 21 |
restriction of middle east | 21 |
more than half of | 21 |
were shown to be | 21 |
have been exposed to | 21 |
polymerase chain reaction assays | 21 |
in acute respiratory distress | 21 |
the host immune system | 21 |
in mers patients representing | 21 |
in a previous study | 21 |
viral shedding and immunological | 21 |
isolated from the human | 20 |
the upper and lower | 20 |
the past two decades | 20 |
of the importance of | 20 |
during the study period | 20 |
serum samples from the | 20 |
respiratory disease in china | 20 |
dromedary camels are the | 20 |
as well as other | 20 |
from the first imported | 20 |
protein of pipistrellus bat | 20 |
dromedary camels to humans | 20 |
new coronavirus associated with | 20 |
of coronaviruses in bats | 20 |
viruses from patients with | 20 |
of the new coronavirus | 20 |
respiratory syndrome isolation of | 20 |
are natural reservoirs of | 20 |
the active site of | 20 |
a case report of | 20 |
acute respiratory infections in | 20 |
the reciprocal of the | 20 |
the median age of | 20 |
of human isolates revealed | 20 |
of pregnant women with | 20 |
induced acute respiratory distress | 20 |
therapeutic options for middle | 20 |
with human respiratory disease | 20 |
a cluster of cases | 20 |
a recent study showed | 20 |
in human airway epithelial | 20 |
c viruses in bats | 20 |
syndrome coronavirus infection middle | 20 |
patients infected with mers | 20 |
respiratory syndrome coronavirus open | 20 |
the best of our | 20 |
cultured from dromedary camels | 20 |
associated with human respiratory | 20 |
rhesus macaques with mers | 20 |
and complete genome sequence | 20 |
and the proofreading exoribonuclease | 20 |
are shown in fig | 20 |
by the addition of | 20 |
deaths have been reported | 20 |
bat coronavirus hku in | 20 |
spike protein of pipistrellus | 20 |
analysis and virus cultured | 20 |
of the upper respiratory | 20 |
further studies are needed | 20 |
comparative serological study middle | 20 |
as middle east respiratory | 20 |
of pipistrellus bat coronavirus | 20 |
lower than that of | 20 |
a new coronavirus associated | 20 |
information on the epidemiology | 20 |
and is targeted by | 20 |
has been suggested that | 20 |
may be associated with | 20 |
the viral spike glycoprotein | 20 |
syndrome coronavirus open reading | 20 |
syndrome coronavirus and the | 20 |
the coronavirus spike protein | 20 |
neonates born to mothers | 20 |
to the use of | 20 |
treatment of novel coronavirus | 20 |
was isolated from a | 20 |
the limit of detection | 20 |
marked sequence divergence in | 20 |
an essential role in | 20 |
quasispecies that include homologues | 20 |
mice transgenic for human | 20 |
rhesus macaques and common | 20 |
coronavirus hku in japanese | 20 |
antivirals for the emerging | 20 |
recent study showed that | 20 |
a large tertiary care | 20 |
of h n influenza | 20 |
in patients with acute | 20 |
was similar to that | 20 |
presence of viral rna | 20 |
the clinical course of | 20 |
of convalescent plasma and | 20 |
genetics with a full | 20 |
is due to the | 20 |
a prospective descriptive study | 20 |
acute respiratory infections of | 20 |
include homologues of human | 20 |
as a receptor for | 20 |
infection is associated with | 20 |
review of medical records | 20 |
homologues of human isolates | 20 |
it was reported that | 20 |
severe lower respiratory tract | 20 |
influenza other respir viruses | 20 |
proinflammatory cytokines and chemokines | 20 |
it is noteworthy that | 20 |
upe and orf a | 20 |
of the s glycoprotein | 20 |
is related to the | 20 |
at a dose of | 20 |
of rhesus macaques with | 20 |
human isolates revealed through | 20 |
viral shedding in mers | 20 |
and the united states | 20 |
an update on the | 20 |
of a series of | 20 |
by the viral polymerase | 20 |
characterization and complete genome | 20 |
spectrum antivirals for the | 20 |
corticosteroid therapy for critically | 20 |
hku in japanese pipistrelle | 20 |
the activation of the | 20 |
syndrome coronavirus by human | 20 |
virus cultured from dromedary | 20 |
in the current study | 20 |
syndrome coronavirus quasispecies that | 20 |
in an attempt to | 20 |
viral polymerase and the | 20 |
at a multiplicity of | 20 |
under different environmental conditions | 20 |
supplemented with fetal bovine | 20 |
divergence in the spike | 20 |
macaques and common marmosets | 20 |
authors would like to | 20 |
a pivotal role in | 20 |
syndrome isolation of a | 20 |
not included in the | 20 |
the south korean outbreak | 20 |
compound library identifies four | 20 |
h n avian influenza | 20 |
from the human respiratory | 20 |
approved compound library identifies | 20 |
options for middle east | 20 |
for the spread of | 20 |
patients with severe disease | 20 |
of type i interferon | 20 |
and viral shedding in | 20 |
the n protein of | 20 |
sequence divergence in the | 20 |
respiratory syndrome coronavirus quasispecies | 20 |
predictive factors for pneumonia | 20 |
hospitalized patients with middle | 20 |
can be used for | 20 |
and virus cultured from | 20 |
have not yet been | 20 |
respiratory infections of viral | 20 |
humans and dromedary camels | 20 |
targeted by neutralizing antibodies | 20 |
polymerase and the proofreading | 20 |
coronavirus associated with human | 20 |
that include homologues of | 20 |
east respiratory syndrome coronaviruses | 20 |
patients with the middle | 20 |
of the host cell | 20 |
lineage c viruses in | 20 |
prevention and control guidelines | 20 |
direct or indirect contact | 20 |
had no role in | 20 |
reverse genetics with a | 20 |
the impact of the | 20 |
reported from saudi arabia | 20 |
in the field of | 20 |
was found to have | 20 |
respiratory syndrome is associated | 20 |
play important roles in | 20 |
coronavirus quasispecies that include | 20 |
replication in the lungs | 20 |
origin of the novel | 20 |
for the emerging middle | 20 |
evaluate the efficacy of | 20 |
of type i ifn | 20 |
none of the studies | 19 |
neutralization of middle east | 19 |
women with severe acute | 19 |
and antigenicity of the | 19 |
of candidate vaccine approaches | 19 |
coronavirus susceptibility to the | 19 |
novel coronavirus infection in | 19 |
updated information on the | 19 |
to the united states | 19 |
were tested for mers | 19 |
library identifies four small | 19 |
systematic review and exploratory | 19 |
dysregulated type i interferon | 19 |
a crucial role in | 19 |
new virus isolated from | 19 |
and progression to respiratory | 19 |
the quality of the | 19 |
lessons from the coronavirus | 19 |
characterization of betacoronavirus lineage | 19 |
a potential source of | 19 |
pneumonia development and progression | 19 |
for the prevention and | 19 |
in the formation of | 19 |
has been observed in | 19 |
evaluation of candidate vaccine | 19 |
influenza a virus infection | 19 |
as well as their | 19 |
vaccine approaches for mers | 19 |
been reported in the | 19 |
the risk of transmission | 19 |
exceptionally potent neutralization of | 19 |
the epithelial cells of | 19 |
for the generation of | 19 |
natural reservoirs of sars | 19 |
third week of illness | 19 |
clinically developed drugs for | 19 |
animal models for sars | 19 |
genetic characterization of betacoronavirus | 19 |
as a treatment of | 19 |
which is consistent with | 19 |
the prevention of human | 19 |
best of our knowledge | 19 |
of betacoronavirus lineage c | 19 |
with the index patient | 19 |
was first isolated in | 19 |
a new virus isolated | 19 |
sequencing and phylogenetic analysis | 19 |
coronavirus by human monoclonal | 19 |
shedding in mers patients | 19 |
at high risk for | 19 |
to the antiviral remdesivir | 19 |
induction of proinflammatory cytokines | 19 |
respiratory disease associated with | 19 |
from the coronavirus disease | 19 |
history of contact with | 19 |
for the management of | 19 |
the time of writing | 19 |
occurred in saudi arabia | 19 |
use of mechanical ventilation | 19 |
syndrome coronavirus infection clinical | 19 |
of respiratory syncytial virus | 19 |
nasal and throat swabs | 19 |
as well as to | 19 |
in vitro inhibition of | 19 |
the detection of sars | 19 |
be used for the | 19 |
of clinically developed drugs | 19 |
mouse model for mers | 19 |
at an moi of | 19 |
molecule inhibitors of middle | 19 |
of innate antiviral response | 19 |
the international health regulations | 19 |
coronavirus infections in health | 19 |
transmission of severe acute | 19 |
the discovery of the | 19 |
cases with onset of | 19 |
for hospitalized patients with | 19 |
in the near future | 19 |
the risk of infection | 19 |
i and ii pneumocytes | 19 |
potent neutralization of middle | 19 |
important lessons from the | 19 |
cd t cell responses | 19 |
of avian influenza a | 19 |
the use of ribavirin | 19 |
at the plasma membrane | 19 |
chain reaction assays for | 19 |
plasma and hyperimmune immunoglobulin | 19 |
the authors would like | 19 |
article distributed under the | 19 |
the outbreak in south | 19 |
the novel coronavirus disease | 19 |
chloroquine is a potent | 19 |
to the control group | 19 |
hyperimmune immunoglobulin for the | 19 |
an increase in the | 19 |
cytokine storm and immunopathology | 19 |
of cytokine storm and | 19 |
transmembrane serine protease tmprss | 19 |
the natural reservoir of | 19 |
cd t cells and | 19 |
to the host cell | 19 |
is targeted by neutralizing | 19 |
it has been suggested | 19 |
prophylactic and postexposure efficacy | 19 |
and hyperimmune immunoglobulin for | 19 |
characteristics of and important | 19 |
syndrome severe acute respiratory | 19 |
potential for human emergence | 19 |
type i interferon and | 19 |
recommendations for hospitalized patients | 19 |
was admitted to the | 19 |
with the severe acute | 19 |
of hepatitis c virus | 19 |
environmental contamination and viral | 19 |
clinical management of severe | 19 |
respiratory syndrome coronavirus nsp | 19 |
n influenza a virus | 19 |
repurposing of clinically developed | 19 |
acute respiratory syndrome a | 19 |
discovery of middle east | 19 |
detection of severe acute | 19 |
the first time in | 19 |
infections of viral etiology | 19 |
and important lessons from | 19 |
h at room temperature | 19 |
type i ifn production | 19 |
was obtained from the | 19 |
respiratory syndrome coronavirus causes | 19 |
coronavirus spike protein and | 19 |
from dromedary camels to | 19 |
the decision to submit | 19 |
factors for pneumonia development | 19 |
dependent rna polymerase from | 19 |
a first step in | 19 |
the mode of transmission | 19 |
has also been shown | 19 |
inhibitor of sars coronavirus | 19 |
in relation to the | 19 |
over the course of | 19 |
extent of the epidemic | 19 |
i interferon production by | 19 |
consequences of cytokine storm | 19 |
be attributed to the | 19 |
of and important lessons | 19 |
in the presence or | 19 |
candidate vaccine approaches for | 19 |
is associated with high | 19 |
into the human population | 19 |
cases were reported in | 19 |
on the development of | 19 |
an urgent need to | 19 |
to those of the | 19 |
was isolated from the | 19 |
in comparison with the | 19 |
to determine whether the | 19 |
thought to be the | 19 |
contamination and viral shedding | 19 |
is caused by a | 19 |
immunoglobulin for the treatment | 19 |
the sars epidemic in | 19 |
retrospective review of medical | 19 |
patients in saudi arabia | 19 |
from the lower respiratory | 19 |
animals vaccinated with chadox | 19 |
near the arabian peninsula | 19 |
the disease caused by | 19 |
acute respiratory syndrome sars | 19 |
susceptibility to the antiviral | 19 |
figure s in supplementary | 19 |
have been found to | 19 |
in the aftermath of | 19 |
of cd t cells | 19 |
causes and consequences of | 19 |
the expression levels of | 19 |
infectious virus was detected | 19 |
transmission potential of covid | 18 |
evolution of human coronavirus | 18 |
and intrauterine vertical transmission | 18 |
access article distributed under | 18 |
mers coronavirus middle east | 18 |
compared to that in | 18 |
to the viral spike | 18 |
collected according to local | 18 |
have been observed in | 18 |
screening for middle east | 18 |
acid are potent inhibitors | 18 |
the democratic republic of | 18 |
of nsp and nsp | 18 |
hydroxychloroquine and azithromycin as | 18 |
investigations and implications for | 18 |
of the most important | 18 |
the first report of | 18 |
of cases from the | 18 |
lethal pneumonia in sars | 18 |
in the control group | 18 |
the spread of this | 18 |
molecular biology of coronaviruses | 18 |
the absence of the | 18 |
the context of a | 18 |
coronavirus accessory protein a | 18 |
is supported by a | 18 |
the rbd of the | 18 |
south korea and china | 18 |
of human bronchial epithelial | 18 |
all authors contributed to | 18 |
and incubated for h | 18 |
the host cell membrane | 18 |
local customs from dromedary | 18 |
neutralizing antibodies in mice | 18 |
from the chinese center | 18 |
characterization of severe acute | 18 |
closely related to sars | 18 |
sars cases with onset | 18 |
structure of the mers | 18 |
antigenicity of the sars | 18 |
and azithromycin as a | 18 |
east respiratory syndrome and | 18 |
has also been reported | 18 |
the virus to the | 18 |
healthcare worker and family | 18 |
for each of the | 18 |
bat coronaviruses shows potential | 18 |
clinical characteristics and intrauterine | 18 |
syndrome coronavirus m protein | 18 |
coalition for epidemic preparedness | 18 |
coronavirus infection and spread | 18 |
to an intensive care | 18 |
and other coronavirus infections | 18 |
as a vaccine candidate | 18 |
neutralizing monoclonal antibody specifically | 18 |
was added to each | 18 |
produced by infection of | 18 |
ill patients with the | 18 |
shows potential for human | 18 |
is important for the | 18 |
that the use of | 18 |
intrauterine vertical transmission potential | 18 |
was performed using a | 18 |
during the h n | 18 |
was performed using the | 18 |
in a pregnant woman | 18 |
in the s subunit | 18 |
prevention and control recommendations | 18 |
summary of a report | 18 |
inhibit the replication of | 18 |
of human immunodeficiency virus | 18 |
for treatment of middle | 18 |
human monoclonal antibody against | 18 |
the emergence of a | 18 |
mycophenolic acid are potent | 18 |
one of the main | 18 |
the emergence of new | 18 |
monoclonal antibody specifically targeting | 18 |
control the spread of | 18 |
from severe acute respiratory | 18 |
respiratory syndrome coronavirus orf | 18 |
first cases of middle | 18 |
the potential to be | 18 |
in the production of | 18 |
syndrome coronavirus in cell | 18 |
of circulating bat coronaviruses | 18 |
a treatment of covid | 18 |
s protein of the | 18 |
and mycophenolic acid are | 18 |
in a tertiary hospital | 18 |
monoclonal antibodies to the | 18 |
characteristics and intrauterine vertical | 18 |
clinical and laboratory findings | 18 |
a safe and effective | 18 |
shown in figure a | 18 |
is similar to that | 18 |
the korea centers for | 18 |
and implications for the | 18 |
respiratory syndrome coronavirus m | 18 |
as a reservoir for | 18 |
with onset of illness | 18 |
suppression of innate antiviral | 18 |
treated with a combination | 18 |
infection in saudi arabia | 18 |
cov spike protein induces | 18 |
sars coronavirus infection in | 18 |
was first isolated from | 18 |
highlight the importance of | 18 |
have no conflict of | 18 |
lower respiratory tract disease | 18 |
the rbd of mers | 18 |
use of laboratory animals | 18 |
cov s protein and | 18 |
results of an open | 18 |
at the s s | 18 |
to local customs from | 18 |
a significant increase in | 18 |
further studies are required | 18 |
preventing the spread of | 18 |
in a number of | 18 |
customs from dromedary camels | 18 |
syndrome in a large | 18 |
convalescent plasma and hyperimmune | 18 |
genome sequence of the | 18 |
respiratory syndrome coronavirus envelope | 18 |
like cluster of circulating | 18 |
developed drugs for treatment | 18 |
of human coronavirus genomes | 18 |
first step in understanding | 18 |
the enzymatic activity of | 18 |
cluster of circulating bat | 18 |
a b and ribavirin | 18 |
is part of the | 18 |
according to local customs | 18 |
a high rate of | 18 |
under the control of | 18 |
in mice transgenic for | 18 |
virus entry and syncytia | 18 |
human coronavirus in a | 18 |
respiratory syndrome severe acute | 18 |
the united states and | 18 |
circulating bat coronaviruses shows | 18 |
receptor for sars coronavirus | 18 |
target for vaccine and | 18 |
for vaccine and therapeutic | 18 |
we were able to | 18 |
the diagnosis and treatment | 18 |
as well as for | 18 |
innate antiviral response by | 18 |
east respiratory syndrome is | 18 |
composition and divergence of | 18 |
evidence of middle east | 18 |
was reported to be | 18 |
the korean mers outbreak | 18 |
of the murine coronavirus | 18 |
features of the first | 18 |
and use of laboratory | 18 |
the characteristics of the | 18 |
use of personal protective | 18 |
implications for the prevention | 18 |
control recommendations for hospitalized | 18 |
to the presence of | 18 |
for h at room | 18 |
of modified endoplasmic reticulum | 18 |
and control recommendations for | 18 |
could be explained by | 18 |
is estimated to be | 18 |
in a biosafety level | 18 |
in nine pregnant women | 18 |
responses to mers coronavirus | 18 |
the nucleocapsid protein of | 18 |
molecular evolution of human | 18 |
cov was detected in | 18 |
and transmission of middle | 18 |
among health care workers | 18 |
vertical transmission potential of | 18 |
coronaviruses shows potential for | 18 |
of a report of | 18 |
asymptomatic middle east respiratory | 18 |
by the viral spike | 18 |
hospital in south korea | 18 |
are those of the | 18 |
due to the fact | 18 |
from bats to humans | 18 |
s protein of mers | 18 |
the third week of | 18 |
can be activated by | 18 |
a fatality rate of | 18 |
and consequences of cytokine | 18 |
was defined as the | 18 |
review and exploratory meta | 18 |
severe respiratory disease in | 18 |
in milk collected according | 18 |
milk collected according to | 18 |
macrophages and dendritic cells | 18 |
play a major role | 18 |
were obtained from the | 18 |
antibodies in milk collected | 18 |
the nature of the | 18 |
cases from the chinese | 18 |
in a large tertiary | 18 |
development and progression to | 18 |
syndrome coronavirus envelope protein | 18 |
and the lack of | 18 |
the transmission of sars | 18 |
is no evidence of | 18 |
the viral life cycle | 18 |
institutional review board of | 18 |
infection in nine pregnant | 18 |
were washed with pbs | 18 |
are responsible for the | 18 |
a higher risk of | 18 |
risk factors of mers | 18 |
in treatment of covid | 18 |
dromedary camels and humans | 18 |
an emerging infectious disease | 18 |
neutralizing monoclonal antibodies to | 18 |
when compared to the | 18 |
potent inhibitors of middle | 18 |
entry and syncytia formation | 18 |
admitted to hospital with | 18 |
association of higher mers | 17 |
as an intermediate host | 17 |
i and type iii | 17 |
of the newly identified | 17 |
convalescent plasma therapy for | 17 |
genome analysis and virus | 17 |
the purpose of this | 17 |
responses cause lethal pneumonia | 17 |
since the emergence of | 17 |
clinical features of the | 17 |
with ic values of | 17 |
domain in middle east | 17 |
a patient with severe | 17 |
immune responses to the | 17 |
novel coronavirus outbreak in | 17 |
confirmed cases of covid | 17 |
cells infected with sars | 17 |
patients in hong kong | 17 |
the rational design of | 17 |
human betacoronavirus lineage c | 17 |
of bat coronavirus hku | 17 |
i interferon and inflammatory | 17 |
by human neutralizing monoclonal | 17 |
have contributed to the | 17 |
east respiratory syndrome with | 17 |
prevalence of comorbidities in | 17 |
coronavirus infection in hospital | 17 |
of bat coronaviruses in | 17 |
rna and neutralising antibodies | 17 |
respiratory syndrome coronavirus nucleocapsid | 17 |
a humanized neutralizing antibody | 17 |
network of modified endoplasmic | 17 |
this version posted may | 17 |
was also observed in | 17 |
neutralising antibodies in milk | 17 |
coronaviruses into the spotlight | 17 |
coronavirus by characterization of | 17 |
have shown that the | 17 |
with a fatality rate | 17 |
lineage c virus in | 17 |
of human neutralizing antibodies | 17 |
design of hydroxychloroquine for | 17 |
viral rna in the | 17 |
by characterization of a | 17 |
activity and projection of | 17 |
nucleocapsid proteins function as | 17 |
in the emergence of | 17 |
direct contact with the | 17 |
the effectiveness of convalescent | 17 |
and united arab emirates | 17 |
results of this study | 17 |
in human ex vivo | 17 |
and their healthcare worker | 17 |
were positive for mers | 17 |
there was a statistically | 17 |
in a macaque model | 17 |
of the present study | 17 |
cov by human neutralizing | 17 |
coronavirus severe acute respiratory | 17 |
date of symptom onset | 17 |
protein inhibits type i | 17 |
in the last years | 17 |
and in vivo studies | 17 |
was based on the | 17 |
have been isolated from | 17 |
health care workers in | 17 |
end of the genome | 17 |
there has been a | 17 |
the extent to which | 17 |
was considered statistically significant | 17 |
antibodies to the viral | 17 |
a conspecific virus from | 17 |
influenza virus h n | 17 |
our results showed that | 17 |
by the end of | 17 |
there is currently no | 17 |
the entry of the | 17 |
and projection of optimized | 17 |
ebola virus disease therapeutics | 17 |
type ii transmembrane serine | 17 |
to mers coronavirus infection | 17 |
study showed that the | 17 |
characteristics of novel coronavirus | 17 |
and neutralising antibodies in | 17 |
and the need for | 17 |
antiviral activity and projection | 17 |
no reuse allowed without | 17 |
and perinatal outcomes of | 17 |
protein of the novel | 17 |
hydroxychloroquine for the treatment | 17 |
and nucleocapsid proteins function | 17 |
first confirmed cases of | 17 |
cases from saudi arabia | 17 |
caused by the novel | 17 |
function as interferon antagonists | 17 |
distribution of ace protein | 17 |
trial of ebola virus | 17 |